𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease

✍ Scribed by Karin F Wader; Unn-Merete Fagerli; Magne Børset; Stian Lydersen; Håkon Hov; Anders Sundan; Anna Bofin; Anders Waage

Book ID
108781244
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
740 KB
Volume
60
Category
Article
ISSN
0309-0167

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of hepatocyte growth factor a
Expression of hepatocyte growth factor and c-MET in skull base chordoma
✍ Takahiko Naka; Doerthe Kuester; Carsten Boltze; Stefanie Scheil-Bertram; Amir Sa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract ## BACKGROUND. Hepatocyte growth factor (HGF) is a multipotent cytokine that is mediated by its receptor, c‐MET. HGF/c‐MET contributes to tumor progression in many human malignancies; however, HGF/c‐MET is inversely correlated with aggressive biologic behavior in other cancers. Convers

Hepatocyte growth factor/scatter factor
Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor
✍ Julius Klominek; Berivan Baskin; Zhiwen Liu; Dan Hauzenberger 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB 👁 2 views

Hepatocyte growth factor (HGF) and its receptor c-met are present in several human tissues but their expression in mesothelial cells has not been examined. In this study, we have investigated the expression of HGF and c-met in normal human mesothelial cells and 11 human malignant mesothelioma cell l

Tumor angiogenesis, hepatocyte growth fa
Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma
✍ Satoshige Wagatsuma; Ryo Konno; Shinji Sato; Akira Yajima 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 1 views

## Background: This study was designed to evaluate the significance of tumor angiogenesis and angiogenic factors such as hepatocyte growth factor (hgf) and c-met in determining the prognoses of 93 patients with endometrial carcinoma. ## Methods: By immunohistochemical staining, this retrospective